The study included more than 20000 Chinese adults with hypertension but no history of stroke or heart disease. Some participants used enalapril (a hypertension drug) and folic acid, while others used enalapril alone.
During the 4.5-year treatment period, 282 participants (2.7%) in the enalapril folic acid group had first stroke, while 355 participants (3.4%) in the enalapril group had a risk reduction of 0.7% and a relative risk reduction of 21%.

We recommend better foic acid:
Magnafolate® L Methylfolate—maximizes the supplementation delivering a "finished" folic acid the body can immediately use without any kind of metabolization.
It can better supplement the folic acid that the body lacks.
Jinkang Pharma ,the Manufacturer & Supplier of L Methylfolate.

Español
Português
русский
Français
日本語
Deutsch
tiếng Việt
Italiano
Nederlands
ภาษาไทย
Polski
한국어
Svenska
magyar
Malay
বাংলা ভাষার
Dansk
Suomi
हिन्दी
Pilipino
Türkçe
Gaeilge
العربية
Indonesia
Norsk
تمل
český
ελληνικά
український
Javanese
فارسی
தமிழ்
తెలుగు
नेपाली
Burmese
български
ລາວ
Latine
Қазақша
Euskal
Azərbaycan
Slovenský jazyk
Македонски
Lietuvos
Eesti Keel
Română
Slovenski
मराठी
Srpski језик 







Online Service